The use of transient elastography and non‐invasive serum markers of fibrosis in pediatric liver transplant recipients

The use of non‐invasive markers to diagnose liver allograft fibrosis is not well established in children after LTx. TE, FT, and ELF score were performed in 117 liver‐transplanted children (60M, 8.9 [0.5–18.5] yr) and 336 healthy controls. Liver biopsy was available in 36 children. Results of histology and non‐invasive markers were compared using correlation coefficient or Mann–Whitney U‐test as appropriate. TE correlated best with histological degree of fibrosis (r = 0.85 vs. r = 0.04 [FT] or r = −0.38 [ELF]). Liver stiffness values for transplanted children without fibrosis were significantly higher than those of healthy controls (7.55 [5.4–20.4] kPa vs. 4.5 [2.5–8.9] kPa). Presence of rejection was a potent confounder for the performance of TE. Both TE and FT reflected clinical changes (acute rejection, cholestasis, increasing fibrosis) in a total of 16 patients who underwent serial measurements. TE correlates better with histological degree of fibrosis in liver‐transplanted children than FT or ELF, but an individual baseline value needs to be determined for each patient. Normal or cutoff values for pathological degrees of fibrosis cannot be transferred from non‐transplanted children. Follow‐up studies, preferably with protocol biopsies, might help to improve the diagnostic quality of TE.

[1]  A. Zapf,et al.  Application and Limitations of Transient Liver Elastography in Children , 2013, Journal of pediatric gastroenterology and nutrition.

[2]  A. Dhawan,et al.  Transient Elastography Is a Useful Noninvasive Tool for the Evaluation of Fibrosis in Paediatric Chronic Liver Disease , 2013, Journal of pediatric gastroenterology and nutrition.

[3]  C. Sempoux,et al.  Novel Histologic Scoring System for Long‐Term Allograft Fibrosis After Liver Transplantation in Children , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  Rosa Gilabert,et al.  ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. , 2012, Journal of hepatology.

[5]  G. Engelmann,et al.  Feasibility study and control values of transient elastography in healthy children , 2012, European Journal of Pediatrics.

[6]  L. Demelia,et al.  Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's Disease. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[7]  M. C. Bojórquez-Ramos,et al.  Non-invasive markers of liver fibrosis in chronic liver disease in a group of Mexican children. A multicenter study. , 2012, Annals of hepatology.

[8]  J. Mate,et al.  Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial , 2012, Scandinavian journal of gastroenterology.

[9]  Xiong Ma,et al.  [Validation of transient elastography (Fibroscan) in assessment of hepatic fibrosis in autoimmune hepatitis]. , 2011, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[10]  J. Nousbaum,et al.  Transient elastography and portal hypertension in pediatric patients with cystic fibrosis Transient elastography and cystic fibrosis. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[11]  J. Barnard,et al.  Safety of Pediatric Percutaneous Liver Biopsy Performed by Interventional Radiologists , 2011, Journal of pediatric gastroenterology and nutrition.

[12]  M. Fukuzawa,et al.  Graft fibrosis in patients with biliary atresia after pediatric living‐related liver transplantation , 2011, Pediatric transplantation.

[13]  Y. Ngo,et al.  Prognostic value of liver fibrosis biomarkers: a meta-analysis. , 2011, Gastroenterology & hepatology.

[14]  Y. Poovorawan,et al.  Transient elastography for predicting esophageal/gastric varices in children with biliary atresia , 2011, BMC gastroenterology.

[15]  D. Häussinger,et al.  Liver fibrosis in recessive multicystic kidney diseases: transient elastography for early detection , 2011, Pediatric Nephrology.

[16]  S. Honsawek,et al.  Increased osteopontin and liver stiffness measurement by transient elastography in biliary atresia. , 2010, World journal of gastroenterology.

[17]  C. Çeltik,et al.  The role of the non-invasive serum marker FibroTest–ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection , 2010, Scandinavian journal of infectious diseases.

[18]  G. Alexander,et al.  Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease , 2010, Gut.

[19]  P. Lebecque,et al.  Transient elastography in patients with cystic fibrosis , 2010, Pediatric Radiology.

[20]  F. Nevens,et al.  Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease. , 2009, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[21]  A. Tran,et al.  Noninvasive Procedures to Evaluate Liver Involvement in HIV-1 Vertically Infected Children , 2009, Journal of pediatric gastroenterology and nutrition.

[22]  S. Kim,et al.  Hepatic Fibrosis Scan for Liver Stiffness Score Measurement: A Useful Preendoscopic Screening Test for the Detection of Varices in Postoperative Patients With Biliary Atresia , 2009, Journal of pediatric gastroenterology and nutrition.

[23]  A. Caro-Patón,et al.  FibroScan evaluation of liver fibrosis in liver transplantation. , 2009, Transplantation proceedings.

[24]  P. Marcellin,et al.  Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest–ActiTest) in patients infected by hepatitis B virus , 2009, Journal of viral hepatitis.

[25]  H. Verkade,et al.  Graft fibrosis after pediatric liver transplantation: Ten years of follow‐up , 2009, Hepatology.

[26]  P. Andreone,et al.  Assessment of liver fibrosis in transplant recipients with recurrent HCV infection: usefulness of transient elastography. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[27]  F. Marra,et al.  Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis , 2008, Hepatology.

[28]  Y. Maehara,et al.  Assessment of Graft Fibrosis by Transient Elastography in Patients With Recurrent Hepatitis C After Living Donor Liver Transplantation , 2008, Transplantation.

[29]  I. Guha,et al.  Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers , 2007, Hepatology.

[30]  V. de Lédinghen,et al.  Liver Stiffness Measurement in Children Using FibroScan: Feasibility Study and Comparison With Fibrotest, Aspartate Transaminase to Platelets Ratio Index, and Liver Biopsy , 2007, Journal of pediatric gastroenterology and nutrition.

[31]  S. Hübscher,et al.  Progressive histological damage in liver allografts following pediatric liver transplantation , 2006, Hepatology.

[32]  Joanna Cielecka-Kuszyk,et al.  Inter-observer variability in histopathological assessment of liver biopsies taken in a pediatric open label therapeutic program for chronic HBV infection treatment. , 2006, World journal of gastroenterology.

[33]  V. de Lédinghen,et al.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study , 2005, Gut.

[34]  R. Porte,et al.  Graft Loss After Pediatric Liver Transplantation , 2002, Annals of surgery.

[35]  K. Ishak,et al.  Histological grading and staging of chronic hepatitis. , 1995 .

[36]  T. Poynard,et al.  Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infection. , 2010, Gastroenterologie clinique et biologique.

[37]  W. Rosenberg,et al.  Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. , 2009, Gastroenterology.

[38]  P. Schlichting,et al.  Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen. , 1983, Scandinavian journal of gastroenterology.